4.7 Article

Galangin induces the osteogenic differentiation of human amniotic mesenchymal stem cells via the JAK2/STAT3 signaling pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Naringin promotes osteogenesis and ameliorates osteoporosis development by targeting JAK2/STAT3 signalling

Wang Wang et al.

Summary: Naringin promotes bone mesenchymal stem cell proliferation and osteogenic differentiation, suppresses JAK2/STAT3 pathway activation, alleviates bone loss, and improves abnormal bone metabolism in postmenopausal osteoporosis rats, thus ameliorating osteoporosis development.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2022)

Review Immunology

Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review

Teklie Mengie Ayele et al.

Summary: The JAK2/STAT3 signaling pathway plays a crucial role in regulating various biological processes such as cell proliferation, differentiation, apoptosis, and immune system control. Aberrantly activated JAK2/STAT3 is associated with the development and metastasis of various tumors, while the JAK3/STAT3 pathway shows promise as a potential therapeutic target in solid tumor treatment.

JOURNAL OF INFLAMMATION RESEARCH (2022)

Review Biochemistry & Molecular Biology

Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells

Quan-Wen Liu et al.

Summary: Stem cell therapy has the potential to repair tissues and improve functional recovery, but faces challenges such as ethical barriers and immune rejection. Human amnion-derived stem cells (hADSCs) show advantages over other stem cells, including high pluripotency and immunomodulatory effects, making them a promising source for cell therapy and regenerative medicine.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

A Review of Recent Developments in the Molecular Mechanisms of Bone Healing

Emerito Carlos Rodriguez-Merchan

Summary: This article reviews recent findings on the molecular mechanisms of bone healing and presents various biological alternatives for treating recalcitrant nonunions, such as using morin, BMP9, and leptin. It also discusses factors that impact bone regeneration, including inhibition of estrogen receptor signaling, smoking-induced inflammatory responses, and delayed fracture healing in diabetic animals due to BMP6 deficiency. The combination of bioceramics and expanded autologous human mesenchymal stem cells from bone marrow is highlighted as a promising alternative for treating nonunions that do not respond well to traditional treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Engineering, Biomedical

Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications

Fatemeh Poustchi et al.

Summary: Combination therapy offers advantages such as simultaneous alteration of biological pathways, reduced drug resistance, and lower treatment costs. Injectable hydrogels serve as an excellent carrier for delivering therapeutic payloads and improving therapeutic responses by forming depots in the body.

ADVANCED HEALTHCARE MATERIALS (2021)

Article Rheumatology

The Jak/STAT pathway: A focus on pain in rheumatoid arthritis

Lee S. Simon et al.

Summary: Pain in rheumatoid arthritis can be treated by cytokines regulated by the Jak/STAT pathway, which play important roles in regulating inflammation and pain mechanisms.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

Article Cell & Tissue Engineering

STAT3 activation by catalpol promotes osteogenesis-angiogenesis coupling, thus accelerating osteoporotic bone repair

Liang Chen et al.

Summary: The study found that catalpol can enhance the osteogenic ability of bone marrow mesenchymal stem cells and promote BMSC-mediated angiogenesis by activating the JAK2/STAT3 signaling pathway. This suggests that catalpol may be an ideal therapeutic agent for the clinical treatment of osteoporotic bone fractures.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell Biology

Galangin suppresses RANKL-induced osteoclastogenesis via inhibiting MAPK and NF-κB signalling pathways

Xiucheng Li et al.

Summary: Galangin treatment effectively reduces osteoclastogenesis in bone marrow-derived macrophages and inhibits the expression of osteoclast-specific genes, leading to impaired bone resorption function. Furthermore, Galangin exerts its therapeutic effects on osteoporosis by inhibiting the MAPK and NF-kappa B signaling pathways.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Medicine, Research & Experimental

A comprehensive review on chemotherapeutic potential of galangin

Shailima Rampogu et al.

Summary: Galangin, a non-toxic phytochemical, has shown anticancer effects through various mechanisms, including inducing apoptosis and inhibiting angiogenesis. It has also demonstrated significant results in combating different types of cancer when administered in combination with other phytochemicals or gold nanoparticles (GNPs).

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biochemistry & Molecular Biology

Strontium Laminarin polysaccharide modulates osteogenesis-angiogenesis for bone regeneration

Fenbo Ma et al.

Summary: The study synthesized a novel polysaccharide-strontium complex LP-Sr, which promotes bone regeneration by enhancing osteogenesis and angiogenesis. Experimental results show that LP-Sr effectively increases cell proliferation and gene expression levels, while suppressing the expression of pro-inflammatory factor IL6.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Mathematical & Computational Biology

Molecular docking analysis of piperlongumine with different apoptotic proteins involved in Hepatocellular Carcinoma

Ashish Kumar et al.

Summary: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and numerous signaling pathways are involved in its progression. Piperlongumine has been identified as a potential candidate for the treatment of HCC, exhibiting high negative energy values in molecular docking with various apoptotic proteins. Among the targets, Piperlongumine showed the highest energy value when docked with VEGF receptor 2.

BIOINFORMATION (2021)

Article Cell Biology

Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein

Hui-Yun Hwang et al.

Summary: This study demonstrates that the antidepressant drug sertraline can induce cellular autophagy by targeting mitochondrial VDAC1, providing a potential new drug candidate for autophagy-related diseases. Additionally, sertraline also suppresses tauopathy by promoting the autophagic degradation of MAPT protein.

AUTOPHAGY (2021)

Article Biochemistry & Molecular Biology

Recent Advances in Biomaterials for the Treatment of Bone Defects

Le-Yi Zhang et al.

Organogenesis (2020)

Review Biochemistry & Molecular Biology

Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?

Anna Jaskiewicz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Toxicology

Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor

Tian Yang et al.

CRITICAL REVIEWS IN TOXICOLOGY (2019)

Article Biochemistry & Molecular Biology

Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor

Priyanka Aryappalli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Cell & Tissue Engineering

Expression of Odontogenic and Osteogenic Markers in DPSCs and SHED: A Review

Hii Siew Ching et al.

CURRENT STEM CELL RESEARCH & THERAPY (2017)

Article Biochemistry & Molecular Biology

Taxifolin enhances osteogenic differentiation of human bone marrow mesenchymal stem cells partially via NF-κB pathway

Yun-Jia Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Medicine, Research & Experimental

Galangin inhibits human osteosarcoma cells growth by inducing transforming growth factor-β1-dependent osteogenic differentiation

Chunhong Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Biotechnology & Applied Microbiology

Small molecules and their controlled release that induce the osteogenic/chondrogenic commitment of stem cells

Yingjun Wang et al.

BIOTECHNOLOGY ADVANCES (2015)

Article Plant Sciences

Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids

Stephen Swioklo et al.

JOURNAL OF NATURAL PRODUCTS (2015)

Review Biochemistry & Molecular Biology

Effects of phytoestrogens and other plant-derived compounds on mesenchymal stem cells, bone maintenance and regeneration

Tatjana Schilling et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)

Article Biochemistry & Molecular Biology

AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis

Chang-hong Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Pharmacology & Pharmacy

Stem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration

Patrick T. Brown et al.

CURRENT PHARMACEUTICAL DESIGN (2013)

Review Chemistry, Medicinal

The role of small molecules in bone regeneration

Qian-Qian Han et al.

FUTURE MEDICINAL CHEMISTRY (2013)

Review Cell Biology

Osteocalcin: Skeletal and extra-skeletal effects

Anna Neve et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2013)

Review Biochemistry & Molecular Biology

Flavonoids as dietary regulators of nuclear receptor activity

Yishai Avior et al.

FOOD & FUNCTION (2013)

Article Cell Biology

Chrysin promotes osteogenic differentiation via ERK/MAPK activation

Wenfeng Zeng et al.

PROTEIN & CELL (2013)

Review Cell & Tissue Engineering

Mesenchymal Stem Cell Homing: The Devil Is in the Details

Jeffrey M. Karp et al.

CELL STEM CELL (2009)

Article Chemistry, Medicinal

Osteogenic activities of genistein derivatives were influenced by the presence of prenyl group at ring a

Yan Zhang et al.

ARCHIVES OF PHARMACAL RESEARCH (2008)

Article Multidisciplinary Sciences

Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization

L Hessle et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)